Janice M. Mehnert, Inderjit Mehmi, Judith D. Goldberg, Maya Dimitrova, Perla Arriola, Amrutesh Puranik, Teruyuki Mizutani, Stanzin Idga, Xiaochun Li, Benjamin A. Levinson, Justine Vanessa Cohen, Elizabeth Iannotti Buchbinder, Donald P. Lawrence, Alissa Kalyan, Morgan Simons, Jonah Michael Levine, F. Stephen Hodi, Ryan J. Sullivan, Omid Hamid. "A phase II study of the interleukin-6 (IL-6) receptor blocking antibody sarilumab (Sari) in combination with ipilimumab (Ipi), nivolumab (Nivo) and relatlimab (Rela) in patients with unresectable stage III or stage IV melanoma.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.9510